1490 ONCE-A-DAY DOSING OF TADALAFIL 5 MG VERSUS ON DEMAND 20 MG IN THE TREATMENT OF POST-RADIOTHERAPY ERECTILE DYSFUNCTION: A RANDOMISED PHASE II STUDY

Paolo Gontero(Fondazione Ricerca Molinette), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), A Tizzani(University of Turin), Franco Valentino(Azienda Ospedaliero Universitaria San Giovanni Battista)
The Journal of Urology
March 23, 2010
10.1016/j.juro.2010.02.1227
Cited by 0

Related Papers

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
|European Urology|2015|639
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
|Clinical Lung Cancer|2014|437
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease
|Neuro-Oncology|2013|371